Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0FD0B
|
||||
| Former ID |
DIB014035
|
||||
| Drug Name |
PSN-9301
|
||||
| Synonyms |
P93/01; DPP-IV inhibitor (type 2 diabetes), Probiodrug; Dipeptidyl peptidase IV inhibitor (type 2 diabetes), (OSI) Prosidion; DPP-IV inhibitor (type 2 diabetes), (OSI) Prosidion
|
||||
| Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 2 | [547754] | ||
| Company |
OSI Pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [544485] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.